Open Access

Location of α-tocopherol and α-tocotrienol to heterogeneous cell membranes and inhibition of production of peroxidized cholesterol in mouse fibroblasts

SpringerPlus20143:550

https://doi.org/10.1186/2193-1801-3-550

Received: 17 August 2014

Accepted: 18 September 2014

Published: 23 September 2014

Abstract

Background

α-Tocopherol (α-T) and α-tocotrienol (α-T3) are well recognized as lipophilic antioxidants. Nevertheless, there is limited knowledge on their location in heterogeneous cell membranes. We first investigated the distribution of α-T and α-T3 to the cholesterol-rich microdomains (lipid rafts and caveolae) of heterogeneous cell membranes by incubating these antioxidants with cultured mouse fibroblasts.

Findings

Levels of cellular uptake for α-T and α-T3 were adjusted to the same order, as that of the latter was much more efficient than that of the former in the cultured cells. After ultracentrifugation, α-T and α-T3 were partitioned to the microdomain fractions. When the distribution of α-T and α-T3 was further confirmed by using methyl-β-cyclodextrin (which removes cholesterol from membranes), α-T was suggested to be distributed to the microdomains (approx. 9% of the total uptake). The same treatment did not affect α-T3 content in the microdomain fractions, indicating that α-T3 is not located in these cholesterol-rich domains. However, α-T and α-T3 significantly inhibited the production of peroxidized cholesterol when cells were exposed to ultraviolet-A light.

Conclusions

These results suggest that α-T and α-T3 can act as membranous antioxidants against photo-irradiated cholesterol peroxidation irrespective of their distribution to cholesterol-rich microdomains.

Keywords

α-Tocopherolα-TocotrienolCholesterol hydroperoxideMicrodomainsLipid raftsUltraviolet (UV)-A irradiation

Introduction

α-Tocopherol (α-T) and α-tocotrienol (α-T3) are vitamin E homologs. They possess a chromanol group (which is responsible for free radical-scavenging activity) and hydrocarbon side chains (which allows them to localize in hydrophobic biomembranes) (Niki et al. 1989). Among vitamin E homologues, α-T is known to circulate exclusively in the human body (Hosomi et al. 1997). It is suggested that α-T3 barely circulates in the body because of the specificity of α-T transfer to liver proteins and its rapid and preferential metabolism (Yamashita et al. 2002; Ikeda et al. 2003). However, it has been reported that α-T3 accumulates selectively in the skin tissue of rodents (Ikeda et al. 2000). In addition, α-T3 was reported to possess higher antioxidant activity than α-T in lipid peroxidation in rat liver microsomal membranes and oxidative damage of cytochrome P-450 (Serbinova et al. 1991; Suzuki et al. 1993). Therefore, α-T3 seems to also act as an in vivo antioxidant in biomembranes, as observed for α-T.

Cholesterol is one of the essential lipids constituting cell membranes. Previously, we proposed that cholesterol hydroperoxides (ChOOHs) formed by exposure of skin tissue to ultraviolet (UV)-A irradiation induce skin-photoaging via activation of collagen-hydrolyzing matrix metalloproteinases (MMPs) (Minami et al. 2009). In addition, ChOOHs were found to be produced in the cholesterol-rich domains of cell membranes, namely, microdomains (lipid rafts and caveolae) (Nakamura et al. 2013). Microdomains are recognized as the site of cell membranes where a wide variety of signal transduction pathways start to propagate in the cytoplasm (Simons and Ikonen 1997). Therefore, it is likely that physicochemical changes in the microdomains originating from ChOOHs formation result in the modification of signal transduction leading to MMPs activation.

The aim of the present study was to ascertain the distribution of α-T and α-T3 in the cholesterol-rich microdomains of heterogeneous cell membranes as well as their effectiveness in the inhibition of production of ChOOHs induced by irradiation with UV-A light. Mouse fibroblasts were used as a model of dermal cells and irradiated with UV-A light after treated with α-T or α-T3.

Materials and methods

NIH-3T3 mouse fibroblasts were cultured as described previously (Nakamura et al. 2013). α-T or α-T3, which was dissolved in Dulbecco’s modified Eagle’s medium (DMEM) (final concentrations at 0.05–5 μM containing 0.1% dimethyl sulfoxide), was added to cultured cells and incubated for 24 h. To confirm vitamin E distribution into microdomains after treatment of α-T (5 μM) or α-T3 (0.5 μM), cholesterol was removed by replacement with 10 mM methyl-β-cyclodextrin (MβCD) in serum-free medium (Zidovetzki and Levitan 2007), and cultured cell was further incubated for 30 min. Cells were washed once with 0.5% bovine serum albumin in phosphate-buffered saline (PBS), and then washed twice in PBS. Cell lysates were collected in 1 mL of lysis buffer containing 1% Triton X-100.

For the partition of microdomains in cell membranes, cell lysates were subjected to ultracentrifugation and fractionated as described previously (Nakamura et al. 2013). Each fraction was extracted with hexane for analyses of α-T and α-T3 as described previously (Bando et al. 2003). The procedures of blot analyses of flotillin-1 and thin-layer chromatography (TLC) of cholesterol were the same as described in our preceding publication (Nakamura et al. 2013). Semi-quantitative TLC analysis of cholesterol was performed according to the method described previously (Kotosai et al. 2013).

UV-A irradiation of cells (800 μW at 2 h) was conducted after the incubation with α-T (5 μM) or α-T3 (0.5 μM) for 24 h and replacement with culture medium containing 1 μM hematoporphyrin, and ChOOHs were measured as described previously (Nakamura et al. 2013).

Results are the means ± S.D. (n = 3 or n = 4). Statistical analyses were carried out using the Student’s t-test. P < 0.05 was considered significant.

Results and discussion

Several reports have clarified that cellular uptake of α-T3 is much more efficient than that of α-T when mixed with cultured cells (Saito et al. 2010; Nishio et al. 2013). To adjust the contents of α-T and α-T3 in fibroblasts, α-T and α-T3 (0.05–5 μM) were added to cells and then incubated for 24 h. Treatment at 5 μM and 0.5 μM raised a similar level in cells for α-T (0.70 ± 0.03 nmol/mg protein) and α-T3 (0.43 ± 0.04 nmol/mg protein), respectively (Figure 1). Therefore, we adopted 5 μM for α-T and 0.5 μM for α-T3 for investigation of the distribution of α-T and α-T3 to the microdomains of cell membranes in fibroblasts.
Figure 1

Cellular uptake of α-T and α-T3 at different concentrations. α-T or α-T3 at the concentration in the range between 0.05 and 5 μM was incubated with fibroblasts for 24 h. White bars, α-T; black bars, α-T3. Values are the means ± S.D. (n = 3).

In the partition experiment, microdomain regions were assumed to be fractions 3, 4 and 5, based on the results of dot-blot analysis of a marker protein of microdomains, flotillin-1 (Figure 2A). This figure also shows that flotillin-1 at the fractions 3, 4 and 5 was decreased upon MβCD treatment. Cholesterol in the microdomain region (fraction 4) also decreased notably (~55% of no-treated fraction 4) after the treatment of MβCD (Figure 2B). Thus, it was evident that MβCD treatment could remove cholesterol resulting in the perturbation of microdomain structures (Zidovetzki and Levitan 2007). However, this treatment did not affect the distribution of α-T3 to each fraction (Figure 3). In contrast, α-T content in the microdomain regions was lowered significantly (approx. 9%) by MβCD treatment. Total amount of α-T in the cells after MβCD treatment was significantly decreased from 756.3 ± 27.5 pmol/mg protein to 635.3 ± 42.9 pmol/mg protein, although that of α-T3 showed no significant decrease from 461.3 ± 13.8 pmol/mg protein to 402.9 ± 44.8 pmol/mg protein. It is assumed that some α-T was released in the cultured medium by the disruption of microdomains. These results suggested that α-T (not α-T3) was partially located or bound to cholesterol-rich microdomains. In addition to cholesterol, glycosphingolipids are also highly concentrated in the microdomains. Here, we focused on cholesterol because our preceding study suggest activation of MMPs in the UVA-exposed skin is triggered by preferential formation of ChOOHs in the microdomains (Minami et al. 2009).
Figure 2

Effect of MβCD on the distribution of flotillin-1 and cholesterol in microdomain fractions. After 30 min incubation of fibroblast with serum-free DMEM in the presence of 10 mM MβCD (MβCD (+)) or in the absence of MβCD (MβCD (-)), cell lysates were subjected to ultracentrifugation (268,000 × g for 4 h at 4°C) and split into nine fractions. (A) Dot blot analyses of flotillin-1. (B) Semi-quantitative TLC analyses of cholesterol. Open circles, no treatment; closed circles, treatment with MβCD. Values are the means ± S.D. (n = 3).

Figure 3

Changes in the distribution of α-T and α-T3 upon treatment with Mβ CD. α-T (5 μM) or α-T3 (0.5 μM) was incubated with fibroblasts for 24 h and replaced with serum-free DMEM in the presence of 10 mM MβCD (MβCD (+)) or in the absence of MβCD (MβCD (-)). After incubation for 30 min, cell lysates were subjected to ultracentrifugation and fractionated by the same method as that shown in Figure 2. Open circles, no treatment; closed circles, treatment with MβCD. Values are the means ± S.D. (n = 3). Asterisk indicates a significant difference between treatment group and no-treatment group (P < 0.05).

It has been hypothesized that α-T is not partitioned into microdomains (Atkinson et al. 2010). Whereas, Royer et al. implied that α-T is loosely bound to lipid raft domains (Royer et al. 2009). Lemaire-Ewing et al. emphasized that α-T shows a propensity to associate with lipid raft domains (Lemaire-Ewing et al. 2010). Yoshida et al. demonstrated that tocopherols and tocotrienols have similar mobility within membranes (Yoshida et al. 2003). Serbinova et al. implied that α-T3 is more uniformly distributed in bilayer membranes and possesses higher recycling efficiency from chromanoxy radicals than α-T (Serbinova et al. 1991). However, there are no reports on the distribution of α-T3 to the microdomains in cell membranes. Here, we found that α-T (but not α-T3) was partially localized or bound to cholesterol-rich microdomains, as indicated previously (Royer et al. 2009; Lemaire-Ewing et al. 2010). In contrast, α-T3 is unlikely to be located selectively in cholesterol-rich microdomains or prefers to be located in this region. Furthermore, we investigated the inhibition of production of ChOOHs by α-T (5 μM) or α-T3 (0.5 μM) in fibroblasts. Three ChOOH isomers, cholesterol 7α-hydroperoxide (Ch7αOOH), cholesterol 5α-hydroperoxide (Ch5αOOH) and cholesterol 7β-hydroperoxide (Ch7βOOH)), were then determined by instrumental analyses. Each hydroxy derivative (Ch7αOH, Ch5αOH and Ch7βOH) derived from its respective ChOOH isomer was increased significantly by exposure to UV-A light (Figure 4). However, UV-A-induced production of these ChOOHs was suppressed by treatment with α-T and α-T3. The level of the suppression by α-T3 was approximately the same as that by α-T. Our previous report (Nakamura et al. 2013) indicates that isomeric ChOOHs are produced equally in both microdomains and non-microdomains. Thus, both of α-T and α-T3 seem to suppress the production of ChOOHs at similar degree, although their localization in the microdomains are not the same. The photodynamic actions of hematoporphyrin generate singlet molecular oxygen (1O2) to result in Ch5αOOH as a 1O2-specific oxidation product, and Ch7αOOH and Ch7βOOH can be formed via isomerization of Ch5αOOH (Girotti and Korytowski 2000; Niki 2005). Although cholesterol 6α-hydroperoxide and cholesterol 6β-hydroperoxide are formed in the type-II reaction as minor prodcuts (Korytowski and Girotti 1999), we focused a major product, Ch5αOOH, and its isomerization products. Tocopherols are known to possess efficient 1O2-quenching activity in biomembranes (Fukuzawa et al. 1997). The 1O2-quenching activities of α-T and α-T3 are, theoretically, dependent upon the structure of the chromanol group and independent of the side chains (Gruszka et al. 2008). Our result that α-T3 exerted comparable inhibition to that of α-T implies that α-T3 participates in the prevention of photoaging by effective antioxidation in the skin, even though the behavior of α-T3 in the heterogeneous cell membranes is different from that of α-T.
Figure 4

Inhibitory effect of α-T and α-T3 on the production of ChOOHs in UV-A-irradiated fibroblasts. Cells were irradiated with UV-A light (800 μW) for 2 h in the presence of hematoporphyrin (1 μM). After irradiation, lipids were extracted and subjected to TLC blotting and gas chromatography–mass spectrometry analyses. White bars, no irradiation; black bars, irradiation with UV-A; light-gray bars, irradiation with UV-A after treatment with α-T (5 μM) for 24 h; dark-gray bars, irradiation with UV-A after treatment with α-T3 (0.5 μM) for 24 h. Values are the means ± S.D. (n = 4). Asterisks indicate significant difference between the non-treatment group with irradiation (black bars) and α-T/α-T3-treated group.

In conclusion, it is not evident that α-T3 is located in cholesterol-rich microdomains, although α-T is (at least in part) located or bound to this region of heterogeneous cell membranes. Nevertheless, α-T3 can suppress the production of ChOOHs from membranous cholesterol mediated by the photodynamic actions of hematoporphyrin to the same extent as that seen with α-T.

Abbreviations

α-T: 

α-tocopherol

α-T3: 

α-tocotrienol

ChOOH: 

Cholesterol hydroperoxide

UV: 

Ultraviolet

MMPs: 

Matrix metalloproteinases

DMEM: 

Dulbecco’s modified Eagle’s medium

Ch5αOOH: 

Cholesterol 5α-hydroperoxide

Ch7αOOH: 

Cholesterol 7α-hydroperoxide

Ch7βOOH: 

Cholesterol 7β-hydroperoxide

MβCD: 

Methyl-β-cyclodextrin

1O2

Singlet molecular oxygen.

Declarations

Authors’ Affiliations

(1)
Department of Food Science, Institute of Health Bioscience, Tokushima University Graduate School
(2)
School of Food and Nutrition Sciences, University of Shizuoka

References

  1. Atkinson J, Harroun T, Wassall SR, Stillwell W, Katsaras J: The location and behavior of alpha-tocopherol in membranes. Mol Nutr Food Res 2010, 54: 641-651. 10.1002/mnfr.200900439View ArticleGoogle Scholar
  2. Bando N, Yamanishi R, Terao J: Inhibition of immunoglobulin E production in allergic model mice by supplementation with vitamin E and beta-carotene. Biosci Biotechnol Biochem 2003, 67: 2176-2182. 10.1271/bbb.67.2176View ArticleGoogle Scholar
  3. Fukuzawa K, Matsuura K, Tokumura A, Suzuki A, Terao J: Kinetics and dynamics of singlet oxygen scavenging by alpha-tocopherol in phospholipid model membranes. Free Radic Biol Med 1997, 22: 923-930. 10.1016/S0891-5849(96)00485-6View ArticleGoogle Scholar
  4. Girotti AW, Korytowski W: Cholesterol as a singlet oxygen detector in biological systems. Methods Enzymol 2000, 319: 85-100.View ArticleGoogle Scholar
  5. Gruszka J, Pawlak A, Kruk J: Tocochromanols , plastoquinol, and other biological prenyllipids as singlet oxygen quenchers—determination of singlet oxygen quenching rate constants and oxidation products. Free Radic Biol Med 2008, 45: 920-928. 10.1016/j.freeradbiomed.2008.06.025View ArticleGoogle Scholar
  6. Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K: Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997, 409: 105-108. 10.1016/S0014-5793(97)00499-7View ArticleGoogle Scholar
  7. Ikeda S, Niwa T, Yamashita K: Selective uptake of dietary tocotrienols into rat skin. J Nutr Sci Vitaminol (Tokyo) 2000, 46: 129-139.View ArticleGoogle Scholar
  8. Ikeda S, Tohyama T, Yoshimura H, Hamamura K, Abe K, Yamashita K: Dietary alpha-tocopherol decreases alpha-tocotrienol but not gamma-tocotrienol concentration in rats. J Nutr 2003, 133: 428-434.Google Scholar
  9. Korytowski W, Girotti AW: Singlet oxygen adducts of cholesterol: photogeneration and reductive turnover in membrane systems. Photochem Photobiol 1999, 70: 484-489. 10.1111/j.1751-1097.1999.tb08242.xView ArticleGoogle Scholar
  10. Kotosai M, Shimada S, Kanda M, Matsuda N, Sekido K, Shmizu Y, Tokumura A, Nakamura T, Murota K, Kawai Y, Terao J: Plasma HDL reduces nonesterified fatty acid hydroeproxides originating from oxidized LDL: a mechanism for its antioxidant ability. Lipids 2013, 48: 569-578. 10.1007/s11745-013-3779-1View ArticleGoogle Scholar
  11. Lemaire-Ewing S, Desrumaux C, Neel D, Lagrost L: Vitamin E transport, membrane incorporation and cell metabolism: is alpha-tocopherol in lipid rafts an oar in the lifeboat? Mol Nutr Food Res 2010, 54: 631-640. 10.1002/mnfr.200900445View ArticleGoogle Scholar
  12. Minami Y, Kawabata K, Kubo Y, Arase S, Hirasaka K, Nikawa T, Bando N, Kawai Y, Terao J: Peroxidized cholesterol-induced matrix metalloproteinase-9 activation and its suppression by dietary beta-carotene in photoaging of hairless mouse skin. J Nutr Biochem 2009, 20: 389-398. 10.1016/j.jnutbio.2008.04.010View ArticleGoogle Scholar
  13. Nakamura T, Noma A, Shimada S, Ishii N, Bando N, Kawai Y, Terao J: Non-selective distribution of isomeric cholesterol hydroperoxides to microdomains in cell membranes and activation of matrix metalloproteinase activity in a model of dermal cells. Chem Phys Lipids 2013, 174: 17-23.View ArticleGoogle Scholar
  14. Niki E: Lipid peroxidation: Mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 2005, 338: 668-676. 10.1016/j.bbrc.2005.08.072View ArticleGoogle Scholar
  15. Niki E, Yamamoto Y, Takahashi M, Komuro E, Miyama Y: Inhibition of oxidation of biomembranes by tocopherol. Ann N Y Acad Sci 1989, 570: 23-31. 10.1111/j.1749-6632.1989.tb14905.xView ArticleGoogle Scholar
  16. Nishio K, Horie M, Akazawa Y, Shichiri M, Iwahashi H, Hagihara Y, Yoshida Y, Niki E: Attenuation of lipopolysaccharide (LPS)-induced cytotoxicity by tocopherols and tocotrienols. Redox Biol 2013, 1: 97-103. 10.1016/j.redox.2012.10.002View ArticleGoogle Scholar
  17. Royer MC, Lemaire-Ewing S, Desrumaux C, Monier S, Pais de Barros JP, Athias A, Néel D, Lagrost L: 7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E : a specific role for alpha-tocopherol with consequences on cell death. J Biol Chem 2009, 284: 15826-15834. 10.1074/jbc.M808641200View ArticleGoogle Scholar
  18. Saito Y, Nishio K, Ogawa-Akazawa Y, Yamanaka K, Miyama A, Yoshida Y, Noguchi N, Niki E: Cytoprotective effects of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: Tocopherols and tocotrienols exert similar effects by antioxidant function. Free Radic Biol Med 2010, 49: 1542-1549. 10.1016/j.freeradbiomed.2010.08.016View ArticleGoogle Scholar
  19. Serbinova E, Kagan V, Han D, Packer L: Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 1991, 10: 263-275. 10.1016/0891-5849(91)90033-YView ArticleGoogle Scholar
  20. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997, 387: 569-572. 10.1038/42408View ArticleGoogle Scholar
  21. Suzuki YJ, Tsuchiya M, Wassall SR, Choo YM, Govil G, Kagan VE, Packer L: Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 1993, 32: 10692-10699. 10.1021/bi00091a020View ArticleGoogle Scholar
  22. Yamashita K, Ikeda S, Iizuka Y, Ikeda I: Effect of sesaminol on plasma and tissue alpha-tocopherol and alpha-tocotrienol concentrations in rats fed a vitamin E concentrate rich in tocotrienols. Lipids 2002, 37: 351-358. 10.1007/s11745-002-0902-6View ArticleGoogle Scholar
  23. Yoshida Y, Niki E, Noguchi N: Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids 2003, 123: 63-75. 10.1016/S0009-3084(02)00164-0View ArticleGoogle Scholar
  24. Zidovetzki R, Levitan I: Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 2007, 1768: 1311-1324. 10.1016/j.bbamem.2007.03.026View ArticleGoogle Scholar

Copyright

© Nakamura et al.; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.